Multicenter prospective observational study on minimal residual disease of ALL after allogeneic transplantation using circulating cell-free tumor DNA KSGCT1901(ctALL)
Not Applicable
Recruiting
- Conditions
- Acute lymphocytic leukemia
- Registration Number
- JPRN-UMIN000039899
- Lead Sponsor
- Kanto Study Group for Cell Therapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are otherwise classified as unfit by the attending physicians for this research.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method One-year cumulative incidence of ALL relapse
- Secondary Outcome Measures
Name Time Method One-year overall survival, Somatic gene mutation, gene expression and immune cell profile at initial diagnosis and relapse